Terms: = Liver cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2
18 results:
1. Immunologic landscape of human hepatic hemangiomas and epithelioid hemangioendotheliomas.
Thomann S; Metzler T; Tóth M; Schirmacher P; Mogler C
Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38206210
[TBL] [Abstract] [Full Text] [Related]
2. Effects on survival of the adverse event of atezolizumab plus bevacizumab for hepatocellular carcinoma: a multicenter study by the Japan Red Cross liver Study Group.
Takaki S; Kurosaki M; Mori N; Tsuji K; Ochi H; Marusawa H; Nakamura S; Tada T; Narita R; Uchida Y; Akahane T; Kondo M; Kusakabe A; Furuta K; Kobashi H; Arai H; Nonogi M; Tamada T; Hasebe C; Ogawa C; Sato T; Tamaki N; Yasui Y; Tsuchiya K; Izumi N
Invest New Drugs; 2023 Apr; 41(2):340-349. PubMed ID: 36995548
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic impact of splenic vessel involvement and tumor size in distal pancreatectomy for adenocarcinoma: a retrospective multicentric cohort study.
Gantois D; Guilbaud T; Scemama U; Girard E; Picaud O; Lefevre M; Elgani M; Hamidou Z; Moutardier V; Balandraud P; Chirica M; Barbier L; Fuks D; Birnbaum DJ
Langenbecks Arch Surg; 2022 Feb; 407(1):153-165. PubMed ID: 34373941
[TBL] [Abstract] [Full Text] [Related]
4. PU.1 drives specification of pluripotent stem cell-derived endothelial cells to LSEC-like cells.
De Smedt J; van Os EA; Talon I; Ghosh S; Toprakhisar B; Furtado Madeiro Da Costa R; Zaunz S; Vazquez MA; Boon R; Baatsen P; Smout A; Verhulst S; van Grunsven LA; Verfaillie CM
Cell Death Dis; 2021 Jan; 12(1):84. PubMed ID: 33446637
[TBL] [Abstract] [Full Text] [Related]
5. Development of an immune-related prognostic index associated with hepatocellular carcinoma.
Hu B; Yang XB; Sang XT
Aging (Albany NY); 2020 Mar; 12(6):5010-5030. PubMed ID: 32191631
[TBL] [Abstract] [Full Text] [Related]
6. Socioeconomic differences in selection for liver resection in metastatic colorectal cancer and the impact on survival.
Vallance AE; van der Meulen J; Kuryba A; Braun M; Jayne DG; Hill J; Cameron IC; Walker K
Eur J Surg Oncol; 2018 Oct; 44(10):1588-1594. PubMed ID: 29895508
[TBL] [Abstract] [Full Text] [Related]
7. Mitochondrial Reprogramming Regulates Breast cancer Progression.
Kannan A; Wells RB; Sivakumar S; Komatsu S; Singh KP; Samten B; Philley JV; Sauter ER; Ikebe M; Idell S; Gupta S; Dasgupta S
Clin Cancer Res; 2016 Jul; 22(13):3348-60. PubMed ID: 26888829
[TBL] [Abstract] [Full Text] [Related]
8. Detrimental Health Effects of Benzene Exposure in Adults After a Flaring Disaster at the BP Refinery Plant in Texas City.
D'Andrea MA; Reddy GK
Disaster Med Public Health Prep; 2016 Apr; 10(2):233-9. PubMed ID: 26880082
[TBL] [Abstract] [Full Text] [Related]
9. SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.
Ran LK; Chen Y; Zhang ZZ; Tao NN; Ren JH; Zhou L; Tang H; Chen X; Chen K; Li WY; Huang AL; Chen J
Clin Cancer Res; 2016 Jul; 22(13):3372-82. PubMed ID: 26861461
[TBL] [Abstract] [Full Text] [Related]
10. Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring-The TADE Study.
Fox P; Balleine RL; Lee C; Gao B; Balakrishnar B; Menzies AM; Yeap SH; Ali SS; Gebski V; Provan P; Coulter S; Liddle C; Hui R; Kefford R; Lynch J; Wong M; Wilcken N; Gurney H
Clin Cancer Res; 2016 Jul; 22(13):3164-71. PubMed ID: 26847054
[TBL] [Abstract] [Full Text] [Related]
11. Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma.
Diouf M; Bonnetain F; Barbare JC; Bouché O; Dahan L; Paoletti X; Filleron T
Oncologist; 2015 Jan; 20(1):62-71. PubMed ID: 25542450
[TBL] [Abstract] [Full Text] [Related]
12. Distinct development and functions of resident and recruited liver Kupffer cells/macrophages.
Ikarashi M; Nakashima H; Kinoshita M; Sato A; Nakashima M; Miyazaki H; Nishiyama K; Yamamoto J; Seki S
J Leukoc Biol; 2013 Dec; 94(6):1325-36. PubMed ID: 23964119
[TBL] [Abstract] [Full Text] [Related]
13. Endothelial transdifferentiation in hepatocellular carcinoma: loss of Stabilin-2 expression in peri-tumourous liver correlates with increased survival.
Géraud C; Mogler C; Runge A; Evdokimov K; Lu S; Schledzewski K; Arnold B; Hämmerling G; Koch PS; Breuhahn K; Longerich T; Marx A; Weiss C; Damm F; Schmieder A; Schirmacher P; Augustin HG; Goerdt S
Liver Int; 2013 Oct; 33(9):1428-40. PubMed ID: 23870052
[TBL] [Abstract] [Full Text] [Related]
14. Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma.
Tamai T; Uto H; Takami Y; Oda K; Saishoji A; Hashiguchi M; Kumagai K; Kure T; Mawatari S; Moriuchi A; Oketani M; Ido A; Tsubouchi H
World J Gastroenterol; 2011 Nov; 17(44):4890-8. PubMed ID: 22171130
[TBL] [Abstract] [Full Text] [Related]
15. Percutaneous sonographically guided radio frequency ablation of hepatocellular carcinoma: causes of mistargeting and factors affecting the feasibility of a second ablation session.
Lee MW; Lim HK; Kim YJ; Choi D; Kim YS; Lee WJ; Cha DI; Park MJ; Rhim H
J Ultrasound Med; 2011 May; 30(5):607-15. PubMed ID: 21527608
[TBL] [Abstract] [Full Text] [Related]
16. Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center.
Forns X; Ampurdanès S; Sanchez-Tapias JM; Guilera M; Sans M; Sánchez-Fueyo A; Quintó L; Joya P; Bruguera M; Rodés J
J Hepatol; 2001 Aug; 35(2):265-71. PubMed ID: 11580150
[TBL] [Abstract] [Full Text] [Related]
17. Irinotecan-induced immune thrombocytopenia.
Bozec L; Bierling P; Fromont P; Lévi F; Debat P; Cvitkovic E; Misset JL
Ann Oncol; 1998 Apr; 9(4):453-5. PubMed ID: 9636839
[TBL] [Abstract] [Full Text] [Related]
18. Immunohistochemical studies on endothelial cell phenotype in hepatocellular carcinoma.
Nakamura S; Muro H; Suzuki S; Sakaguchi T; Konno H; Baba S; Syed AS
Hepatology; 1997 Aug; 26(2):407-15. PubMed ID: 9252152
[TBL] [Abstract] [Full Text] [Related]
